INDEGENE
Back to Cashflow Statement
|
INDEGENE Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹288 Cr | ₹-66 Cr | ₹333 Cr | ₹233 Cr | ₹-132 Cr |
What is the latest Cash Flow from Financing Activities ratio of INDEGENE ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2025 | ₹288 Cr |
Mar2024 | ₹-66 Cr |
Mar2023 | ₹333 Cr |
Mar2022 | ₹233 Cr |
Mar2021 | ₹-132 Cr |
How is Cash Flow from Financing Activities of INDEGENE Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2025 | ₹288 Cr | Positive | |
Mar2024 | ₹-66 Cr | Negative | |
Mar2023 | ₹333 Cr | 42.67 | |
Mar2022 | ₹233 Cr | Positive | |
Mar2021 | ₹-132 Cr | - |
Compare Cash Flow from Financing Activities of peers of INDEGENE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDEGENE | ₹14,085.5 Cr | 1.8% | -0.8% | -13% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹397,342.0 Cr | 2% | 1.4% | -13% | Stock Analytics | |
DIVIS LABORATORIES | ₹164,555.0 Cr | 1.3% | 0.3% | 10.4% | Stock Analytics | |
CIPLA | ₹127,259.0 Cr | 0.3% | 1.9% | -6.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,898.0 Cr | 0% | -2.3% | 2.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,394.0 Cr | 0.5% | 6.2% | -1.4% | Stock Analytics |
INDEGENE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDEGENE | 1.8% |
-0.8% |
-13% |
SENSEX | 0.9% |
1.2% |
-0.4% |
You may also like the below Video Courses